Evolving Care and Management of Patients With Multidrug-Resistant HIV | Satellite Symposium at IAS 2021

The satellite symposium at IAS 2021 on Evolving Care and Management of Patients With Multidrug-Resistant HIV was held virtually on 19 July 2021. The enduring materials of this program were made available for the following month on the IAS 2021 platform for registered delegates and members. The enduring materials are also available on this meeting page which includes recorded lectures, faculty discussions, and slide sets.

The program focused on learning more about HIV patients with limited treatment options. It addressed available tools to identify these patients, resistance considerations in treatment decisions, and how to tackle polypharmacy, drug-drug interactions, and co-morbidities, among other topics. The program provided insights into new treatment options and how best to integrate them into optimal antiretroviral regimens.

The live stream included lectures and faculty discussions from Dr. Clíona Ní Cheallaigh, Dr. David Back, and Dr. Francois Venter.

• Immune non-responders and how best to define and treat them
• Potential drug interactions with herbal medicines and supplements
• Opportunities and challenges in managing patients in low- and middle-income countries

This activity was intended for all HIV healthcare professionals. Specifically:

• HIV physicians experienced in treating Multidrug-Resistant HIV patients who need to be informed and updated on new treatment options;
• HIV physicians inexperienced in treating Multidrug-Resistant HIV patients who need more comprehensive education on identifying and managing Multidrug-Resistant HIV patients with emphasis on new drugs;
• Clinical pharmacologists involved in the concomitant medication management and dose adjusting for co-morbidities of Multidrug-Resistant HIV patients; and
• Other healthcare professionals (e.g. nurse practitioners) involved in medical care of Multidrug-Resistant HIV patients.

The program on Evolving Care and Management of Patients With Multidrug-Resistant HIV aimed at creating an opportunity to educate HIV treating clinicians on the optimal identification and management of those HIV patients, specifically addressing:

• Immune non-responders;
• Drug Interactions with Herbal Medicines and Supplements; and
• Management of those patients in Low and Middle-Income Countries.

At the completion of this program participants are now able to:

• Increase knowledge on how to define and treat immune non-responders;
• Comprehend potential drug Interactions with herbal medicines and supplements, relevant for treatment of HIV patients with multidrug-resistant HIV; and
• Increase understanding on challenges and opportunities in managing multidrug-resistant HIV in low and medium-income countries.

The Evolving Care and Management of Patients with Multidrug-Resistant HIV, Utrecht (livestream), Netherlands, 19/07/2021-19/07/2021 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

The Evolving Care and Management of Patients With Multidrug-Resistant HIV | Satellite Symposium at IAS 2021 is supported by an independent educational grant from ViiV Healthcare.

ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.